TABLE 1.
Compound code | EC50a (μg/ml) | CC50b (μg/ml) | Maximum protection (%) (at 125 μg/ml) |
---|---|---|---|
5CI-IS-AC | >125 | >125 | 0 |
SPIII-5H | >125 | >125 | 22 |
SPIII-5Cl | >125 | >125 | 10 |
SPIII-5Br | >125 | >125 | 2 |
SPIII-5F | >125 | >125 | 45 |
SPIII-5Me | >125 | >125 | 12 |
SPIII-NA | >125 | >125 | 12 |
50% effective concentration required to reduce virus-induced cytopathicity by 50%.
50% cytotoxic concentration required to reduce host cell viability by 50%